PerkinElmer Launches Industry First No-Wash Immunoassay For Phospho Ubiquitin Ser65 to Help Drive Neuroscience Disease and Therapeutics Research Forward
26.10.2020 22:05:00 EET | Business Wire | Press release
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the life science industry’s first no wash Ubiquitin phosphorylation at Serine 65 immunoassay for studying defective mitophagy biological mechanisms that have been broadly associated with diseases such as Parkinson’s and Alzheimer’s. The new PerkinElmer Cisbio HTRF® Phospho-Ubiquitin (Ser65) Cellular Kit takes analysis efficiency and accuracy to the next level compared to existing techniques such as Western blot and is aimed at helping scientists discover new therapeutic candidates earlier in the disease cycle.
The innovative assay leverages TR-FRET technology to bring high sensitivity across a wide range of analytes and greater study specificity to the Phospho-Ubiquitin (Ser65) intersection point that has been shown to play a key role in mitophagy dysfunction and breakdowns in the complex network between neurons and glial cells which can lead to neurodegenerative disease.
Efficient and streamlined workflows and accelerated data delivery are also provided by the immunoassay’s mix and read method approach and compatibility with microplate readers such as PerkinElmer’s VictorTM Nivo® or EnVision® systems. Analysis can also be automated and run in high throughput formats.
“With over 70 Million people around the world living with Alzheimer’s and Parkinson’s and the sheer complexity of how neurodegenerative disease develops in the brain, it is critical that scientists have the tools they need to help unlock promising avenues of study such as modulating mitophagy impairment,” said Alan Fletcher, VP and GM of Life Sciences, PerkinElmer. “With this new immunoassay, researchers now have a more efficient and effective way to study a key biomarker which could lead to exciting new therapeutic candidates.”
The new PerkinElmer Cisbio HTRF Phospho-Ubiquitin (Ser65) Cellular Kit, joins PerkinElmer’s range of immunoassay kits and reagents for neuroscience applications across HTRF, Alpha, LANCE® and DELFIA®. For more information please visit: https://learn.cisbio.com/lp/guide-neurodegenerative-diseases-and-neuroinflammation-pathways; https://uk.cisbio.eu/dd/by-universe/neuroscience
About PerkinElmer
PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 13,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.9 billion in 2019, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201026005820/en/
Contact information
Jennifer McNeil
+1 508 380 2902
Jennifer.mcneil@perkinelmer.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Draslovka and Avathon Partner to Deliver AI-Powered Solutions for Mining Through Autonomy, MetOptima and Blue Cube Combined Offering10.2.2026 16:00:00 EET | Press release
Draslovka a.s. (“Draslovka”), a global innovator in sustainable chemical technologies and AI‑enabled services for the mining sector, and Avathon, the leader in Autonomy for Operations, today announced a strategic commercial partnership to accelerate the adoption of intelligent, autonomous, and data‑driven operations across the global mining industry. The partnership provides a breakthrough solution that combines Draslovka’s real‑time mineral and slurry monitoring technologies—delivered through its world class Blue Cube on‑stream mineralogical sensors—and MetOptima advanced metallurgical optimization AI engine, with the Avathon Autonomy Platform, a scalable industrial‑AI environment that enhances operational performance, automating decisions, and orchestrating complex operations across sites. Under the agreement, Draslovka and Avathon will collaborate closely on go-to-market initiatives, jointly commercializing and cross‑selling the combined offering. The combined Draslovka‑Avathon offe
Golub Capital Expands Broadly Syndicated Loan CLO Business to Europe10.2.2026 16:00:00 EET | Press release
Today, Golub Capital (“the Firm”) announced the expansion of its BSL CLO strategy to Europe and the appointment of Tyler Wallace as Managing Director, European Broadly Syndicated Loans. Wallace brings more than 20 years of leading credit experience to the Firm and most recently was a Managing Director and Portfolio Manager of CLOs at Fair Oaks Capital in London. “This is a natural expansion for us,” said Scott Morrison, Head of BSL at Golub Capital. “The expansion builds on our market-leading U.S. CLO platform and strengthens our ability to deliver comprehensive financing solutions to partners across Europe.” Said Tyler Wallace, “Golub Capital has an exceptional BSL track record. I am excited to lead this next chapter and bring the Firm’s capabilities to partners in the region.” As of December 31, 2025, Golub Capital manages over $14 billion in broadly syndicated loans and has completed over 60 BSL CLO transactions since 2007. Other key business highlights include: Closed over $9 billi
Telekom Srbija Group Wins Telecom Deal of the Year Award for Landmark $900M Eurobond10.2.2026 15:53:00 EET | Press release
Telekom Srbija Group has been honoured with the Europe Telecom Deal of the Year award at the prestigious TMT Finance Awards EMEA 2026, recognising excellence in telecom financing. The award was given for its US$900 million corporate Eurobond, listed on Euronext Dublin. The award celebrates outstanding dealmaking in the telecom sector across Europe, the Middle East and Africa. The distinguished accolade highlights Telekom Srbija’s strategic success in executing a high-profile international financial transaction that strengthened investor confidence and expanded the company’s footprint in capital markets. This marks a significant milestone in Telekom Srbija Group’s continued growth and global recognition. Vladimir Lučić, CEO of Telekom Srbija Group, said: “We are incredibly proud that our Eurobond has been recognised as Europe Telecom Deal of the Year. This award reflects not just the success of the transaction, but the confidence global investors have in our strategy, our financial stre
Intuit Mailchimp Unlocks a New Era of Profitable Ecommerce Marketing with Advanced, Data-Driven Capabilities10.2.2026 15:30:00 EET | Press release
Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, and Mailchimp, today announced a set of Mailchimp product innovations that unlock profitable growth for ecommerce businesses. Powered by the Intuit platform, the enhancements include more ways for merchants to connect their data and activate omnichannel campaigns driving up to 30x ROI for ecommerce customers1 without the added price or complexity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210726144/en/ Built to deliver ROI for less cost, Intuit Mailchimp now combines unified data with powerful automation across email and messaging. Product innovations available in 185 countries and territories across North America, Latin America, EMEA and APAC. For small and mid-market online sellers, customer acquisition and growth are becoming harder to measure and optimize. Only 33% of marketers say their pre-
Vasion Appoints Scott Lee as Chief Product Officer to Accelerate the Impact of Intelligent Print Automation10.2.2026 15:00:00 EET | Press release
Vasion, a leader in serverless printing and Intelligent Print Automation, today announced the appointment of Scott Lee as Chief Product Officer. Lee brings more than 25 years of C-level product and growth leadership experience transforming and scaling enterprise SaaS companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210803525/en/ Scott Lee joins Vasion as Chief Product Officer, bringing more than 25 years of enterprise SaaS leadership experience to accelerate the company's intelligent print automation platform and AI-ready capabilities. As Chief Product Officer at Vasion, Lee will lead product management, product design, and product operations. He will focus on expanding strong product foundations and ensuring customer value as the company scales. His extensive experience modernizing complex technologies into AI-powered platforms positions him to accelerate growth and innovation at Vasion. "Vasion has long been kn
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom